May 13, 2009 - American College of Radiology (ACR) Image Metrix has been chosen by the Academy of Molecular Imaging (AMI) to provide data and image storage infrastructure for a new study to compare the effectiveness of conventional planar 99mTc-MDP bone imaging with 18F-sodium fluoride PET/CT (18F-NaF) at detecting bony metastases in patients with breast, prostate and non–small-cell lung cancers.

The protocol was developed in conjunction with the U.S. Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS) and calls for data collection on more than 500 patients at 13 sites nationwide.

“Just as early detection of cancer is important, early detection of any spread of a cancer is vitally important to determining the best and most timely treatment for patients. PET and PET/CT are serving an increasingly important role in this care. Each refinement in care can make a big difference in the success of treatment for additional patients. ACR Image Metrix is proud to serve such a significant role in this important trial as the selected CRO [Contract Research Organization],” said ACR Image Metrix Chief Scientific Officer Bruce J. Hillman, M.D., FACR, who worked with AMI investigators to develop the protocol for the research.

Cancer patients undergo more than 2 million planar 99mTc-MDP scans each year to determine whether cancer has spread from the organ of primary diagnosis to their bones. However, the test may miss some disease. 18F-NaF PET/CT bone scanning may have advantages over the conventional method in that it is often able to find smaller metastases and differentiate more accurately between cancerous and non-cancerous conditions.

“ACR Image Metrix is unique in the CRO landscape regarding its ability to assist in protocol development then transmit, archive, and retrieve imaging data for such important trials. We are proud of our ability to substantively contribute to advances in patient care by providing significant infrastructure for cutting edge medical research,” said Michal Morales, General Manager of ACR Image Metrix.

For more information: www.acr.org and www.ami-imaging.org


Related Content

News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | PET Imaging

June 18, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...

Time June 18, 2024
arrow
News | PET Imaging

June 14, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...

Time June 14, 2024
arrow
News | FDA

June 10, 2024 — Siemens Healthineers announces the Food and Drug Administration clearance of the Biograph Trinion, a ...

Time June 10, 2024
arrow
News | Radiology Business

May 14, 2024 — University Hospitals (UH) and Siemens Healthineers announce a 10-year strategic alliance that builds on ...

Time May 14, 2024
arrow
News | Cardiac Imaging

April 23, 2024 — CDL Nuclear Technologies, a pioneer in advanced diagnostic solutions, is proud to announce the launch ...

Time April 23, 2024
arrow
News | FDA

January 23, 2024 — Siemens Healthineers announces the Food and Drug Administration (FDA) clearance of syngo Virtual ...

Time January 23, 2024
arrow
News | Artificial Intelligence

January 23, 2024 — Quibim announced it has added an industry-leading cancer detection capability to its prostate tool ...

Time January 22, 2024
arrow
News | Radiology Business

December 27, 2023 — The American Roentgen Ray Society (ARRS) announced David M. Naeger, MD, as the 2024 ARRS ...

Time December 27, 2023
arrow
News | Radiopharmaceuticals and Tracers

December 6, 2023 — Philochem AG, a wholly owned subsidiary of Philogen S.p.A., and Blue Earth Diagnostics, a Bracco ...

Time December 06, 2023
arrow
Subscribe Now